Repligen
RGEN
#2665
Rank
โ‚ฌ5.63 B
Marketcap
99,97ย โ‚ฌ
Share price
-0.94%
Change (1 day)
-17.49%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): โ‚ฌ72.33 Million

According to Repligen 's latest financial reports the company's current earnings are โ‚ฌ0.73 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ5.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ71.56 M-1430.84%
2024 -โ‚ฌ5.38 Million-113.01%
2023 โ‚ฌ41.32 M-78.01%
2022 โ‚ฌ0.18 B33.37%
2021 โ‚ฌ0.14 B131.52%
2020 โ‚ฌ60.86 M101.31%
2019 โ‚ฌ30.23 M25.93%
2018 โ‚ฌ24 M105.61%
2017 โ‚ฌ11.67 M-11.46%
2016 โ‚ฌ13.18 M14.91%
2015 โ‚ฌ11.47 M20.26%
2014 โ‚ฌ9.54 M-51.49%
2013 โ‚ฌ19.67 M90.98%
2012 โ‚ฌ10.3 M
2010 โ‚ฌ0.14 M-103.81%
2009 -โ‚ฌ3.92 Million-223.84%
2008 โ‚ฌ3.15 M
2006 -โ‚ฌ2.13 Million229.64%
2005 -โ‚ฌ0.65 Million-89.16%
2004 -โ‚ฌ5.95 Million-16.86%
2003 -โ‚ฌ7.15 Million88.72%
2002 -โ‚ฌ3.79 Million-27.88%
2001 -โ‚ฌ5.26 Million-1.74%
2000 -โ‚ฌ5.35 Million85.93%
1999 -โ‚ฌ2.88 Million159.16%
1998 -โ‚ฌ1.11 Million85.71%
1997 -โ‚ฌ0.6 Million-70.83%
1996 -โ‚ฌ2.05 Million-72.41%
1995 -โ‚ฌ7.43 Million-60.63%
1994 -โ‚ฌ18.86 Million45.39%
1993 -โ‚ฌ12.97 Million39.45%
1992 -โ‚ฌ9.3 Million-32.3%
1991 -โ‚ฌ13.74 Million6.62%
1990 -โ‚ฌ12.89 Million1577.78%
1989 -โ‚ฌ0.77 Million-57.14%
1988 -โ‚ฌ1.8 Million-362.5%
1987 โ‚ฌ0.68 M-130.77%
1986 -โ‚ฌ2.22 Million136.36%
1985 -โ‚ฌ0.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ8.69 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ6.23 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚ฌ9.24 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ7.95 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ93 Million-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.39 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.54 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ0.10 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.41 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚ฌ84.88 Million-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA